AAAAAA
Results:
1-20
|
Results: 20
Authors:
Conrad, S
Kauffmann, HM
Ito, K
Deeley, RG
Cole, SPC
Schrenk, D
Citation: S. Conrad et al., Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution, J HUM GENET, 46(11), 2001, pp. 656-663
Authors:
Wille, G
Mayser, P
Thoma, W
Monsees, T
Baumgart, A
Schmitz, HJ
Schrenk, D
Polborn, K
Steglich, W
Citation: G. Wille et al., Malassezin - A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur, BIO MED CH, 9(4), 2001, pp. 955-960
Authors:
Eneroth, A
Astrom, E
Hoogstraate, J
Schrenk, D
Conrad, S
Kauffmann, HM
Gjellan, K
Citation: A. Eneroth et al., Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction, EUR J PH SC, 12(3), 2001, pp. 205-214
Authors:
Schrenk, D
Baus, PR
Ermel, N
Klein, C
Vorderstemann, B
Kauffmann, HM
Citation: D. Schrenk et al., Up-regulation of transporters of the MRP family by drugs and toxins, TOX LETT, 120(1-3), 2001, pp. 51-57
Authors:
Schrenk, D
Citation: D. Schrenk, Special issue - Transmembrane export pumps: Role in toxicology - Editorial, TOXICOLOGY, 167(1), 2001, pp. 1-1
Authors:
Kauffmann, HM
Vorderstemann, B
Schrenk, D
Citation: Hm. Kauffmann et al., Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites, TOXICOLOGY, 167(1), 2001, pp. 25-35
Authors:
Conrad, S
Viertelhaus, A
Orzechowski, A
Hoogstraate, J
Gjellan, K
Schrenk, D
Kauffmann, HM
Citation: S. Conrad et al., Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1, TOXICOLOGY, 156(2-3), 2001, pp. 81-91
Authors:
Bohnenberger, S
Wagner, B
Schmitz, HJ
Schrenk, D
Citation: S. Bohnenberger et al., Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like' polychlorinated biphenyls, CARCINOGENE, 22(10), 2001, pp. 1601-1606
Authors:
Fiedler, H
Furst, P
Malisch, R
Papke, O
Schrenk, D
Citation: H. Fiedler et al., 20th International Symposium on Halogenated Environmental Organic Pollutants & POPS - Monterey, California, USA, August 13-17, 2000, ENV SCI P R, 7(4), 2000, pp. 239-242
Authors:
Scheel, J
Schrenk, D
Citation: J. Scheel et D. Schrenk, Genomic structure of the human Ah receptor nuclear translocator gene (hARNT), HUM GENET, 107(4), 2000, pp. 397-399
Authors:
van den Berg, M
van Birgelen, A
Birnbaum, L
Brouwer, B
Carrier, G
Dragan, Y
Farland, W
Feeley, M
Furst, P
Galli, CL
Greig, J
Hayashi, Y
Kogevinas, M
Kurokawa, Y
Larsen, JC
Liem, AKD
Matsumura, F
Mocarelli, P
Moore, MR
Newhook, RC
Peterson, RE
Poellinger, L
Portier, C
Rogan, WJ
Schrenk, D
Sweeney, MH
Tohyama, C
Tuomisto, J
Waters, J
Zeilmaker, M
Citation: M. Van Den Berg et al., Consultation on assessment of the health risk of dioxins; re-evaluation ofthe tolerable daily intake (TDI): Executive Summary, FOOD ADDIT, 17(4), 2000, pp. 223-240
Authors:
Dragan, YP
Schrenk, D
Citation: Yp. Dragan et D. Schrenk, Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion, FOOD ADDIT, 17(4), 2000, pp. 289-302
Authors:
van den Berg, M
Peterson, RE
Schrenk, D
Citation: M. Van Den Berg et al., Human risk assessment and TEFs, FOOD ADDIT, 17(4), 2000, pp. 347-358
Authors:
van Leeuwen, FXR
Feeley, M
Schrenk, D
Larsen, JC
Farland, W
Younes, M
Citation: Fxr. Van Leeuwen et al., Dioxins: WHO's tolerable daily intake (TDI) revisited, CHEMOSPHERE, 40(9-11), 2000, pp. 1095-1101
Authors:
Westphal, K
Weinbrenner, A
Zschiesche, M
Franke, G
Knoke, M
Oertel, R
Fritz, P
von Richter, O
Warzok, R
Hachenberg, T
Kauffmann, HM
Schrenk, D
Terhaag, B
Kroemer, HK
Siegmund, W
Citation: K. Westphal et al., Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction, CLIN PHARM, 68(4), 2000, pp. 345-355
Authors:
Fromm, MF
Kauffmann, HM
Fritz, P
Burk, O
Kroemer, HK
Warzok, RW
Eichelbaum, M
Siegmund, W
Schrenk, D
Citation: Mf. Fromm et al., The effect of rifampin treatment on intestinal expression of human MRP transporters, AM J PATH, 157(5), 2000, pp. 1575-1580
Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures
Authors:
Till, M
Riebniger, D
Schmitz, HJ
Schrenk, D
Citation: M. Till et al., Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures, CHEM-BIO IN, 117(2), 1999, pp. 135-150
Authors:
Worner, W
Schrenk, D
Citation: W. Worner et D. Schrenk, 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytes, ENV TOX PH, 6(4), 1998, pp. 239-247
Authors:
Kauffmann, HM
Keppler, D
Gant, TW
Schrenk, D
Citation: Hm. Kauffmann et al., Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen, ARCH TOXIC, 72(12), 1998, pp. 763-768
Authors:
Van den Berg, M
Birnbaum, L
Bosveld, ATC
Brunstrom, B
Cook, P
Feeley, M
Giesy, JP
Hanberg, A
Hasegawa, R
Kennedy, SW
Kubiak, T
Larsen, JC
van Leeuwen, FXR
Liem, AKD
Nolt, C
Peterson, RE
Poellinger, L
Safe, S
Schrenk, D
Tillitt, D
Tysklind, M
Younes, M
Waern, F
Zacharewski, T
Citation: M. Van Den Berg et al., Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife, ENVIR H PER, 106(12), 1998, pp. 775-792
Risultati:
1-20
|